BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19366915)

  • 1. Infectious complications associated with monoclonal antibodies and related small molecules.
    Salvana EM; Salata RA
    Clin Microbiol Rev; 2009 Apr; 22(2):274-90, Table of Contents. PubMed ID: 19366915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biologics and infections in rheumatic diseases].
    Hügle T; Daikeler T; Tyndall A
    Ther Umsch; 2014 Jan; 71(1):45-53. PubMed ID: 24394208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review.
    Hadjinicolaou AV; Nisar MK; Bhagat S; Parfrey H; Chilvers ER; Ostör AJ
    Rheumatology (Oxford); 2011 Dec; 50(12):2297-305. PubMed ID: 22019799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biologics. Magic bullets - magic effects - magic costs? New therapeutics and their effects].
    Frey O; Kamradt T
    Ophthalmologe; 2011 Jan; 108(1):7-12. PubMed ID: 21253742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies and side-effect management.
    Muehlbauer PM; Cusack G; Morris JC
    Oncology (Williston Park); 2006 Sep; 20(10 Suppl Nurse Ed):11-21; discussion 22-3. PubMed ID: 18153975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological therapy and neurological manifestations. What do we know?
    Tejera-Segura B; Ferraz-Amaro I
    Reumatol Clin; 2017; 13(2):102-106. PubMed ID: 27373584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of corticosteroid therapy in non-malignant diseases].
    Vignes S; Wechsler B
    Rev Med Interne; 1998 Nov; 19(11):799-810. PubMed ID: 9864778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions to biologic agents and their medical management.
    Boyman O; Comte D; Spertini F
    Nat Rev Rheumatol; 2014 Oct; 10(10):612-27. PubMed ID: 25112605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections associated with monoclonal antibody and fusion protein therapy in humans.
    Uettwiller F; Rigal E; Hoarau C
    MAbs; 2011; 3(5):461-6. PubMed ID: 21822056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in rheumatic diseases.
    Yuvienco C; Schwartz S
    Med Health R I; 2011 Nov; 94(11):320-4. PubMed ID: 22204094
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety issues of biologics in pregnant patients with rheumatic diseases.
    Ostensen M
    Ann N Y Acad Sci; 2014 May; 1317():32-8. PubMed ID: 24840548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infectious complications of biological therapy].
    Holub M; Rozsypal H; Chalupa P
    Klin Mikrobiol Infekc Lek; 2011 Feb; 17(1):24-9. PubMed ID: 21452120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology and therapeutic applications of monoclonal antibodies.
    Castelli MS; McGonigle P; Hornby PJ
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00535. PubMed ID: 31859459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological therapy for the treatment of rheumatic diseases].
    Pierer M; Baerwald C
    Internist (Berl); 2008 Aug; 49(8):938-46. PubMed ID: 18587545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on therapeutic monoclonal antibodies.
    Bussel JB; Giulino L; Lee S; Patel VL; Sandborg C; Stiehm ER
    Curr Probl Pediatr Adolesc Health Care; 2007 Apr; 37(4):118-35. PubMed ID: 17434008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy: Are TNF blockers safe for patients with hepatitis B virus infection?
    Ramos-Casals M
    Nat Rev Rheumatol; 2010 Nov; 6(11):618-20. PubMed ID: 21037559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with monoclonal antibodies and pregnancy in women with systemic inflammatory diseases: A special situation.
    Valor L; Ovalles-Bonilla JG; Hernández-Flórez D; López-Longo FJ
    Reumatol Clin; 2016; 12(6):359-360. PubMed ID: 26948713
    [No Abstract]   [Full Text] [Related]  

  • 18. Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a review.
    Toussirot E; Streit G; Wendling D
    Recent Pat Inflamm Allergy Drug Discov; 2007 Feb; 1(1):39-47. PubMed ID: 19075965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological complications of infliximab.
    Tektonidou MG
    J Rheumatol; 2007 Jan; 34(1):237; author reply 237-8. PubMed ID: 17216701
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.